rs148417330
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM5
The NM_000784.4(CYP27A1):c.491G>A(p.Arg164Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000397 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R164W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000784.4 missense
Scores
Clinical Significance
Conservation
Publications
- cerebrotendinous xanthomatosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Genomics England PanelApp, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152212Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000282 AC: 71AN: 251450 AF XY: 0.000294 show subpopulations
GnomAD4 exome AF: 0.000400 AC: 585AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 274AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000361 AC: 55AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Cholestanol storage disease Uncertain:1Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
Intellectual disability Uncertain:1
- -
CYP27A1-related disorder Uncertain:1
The CYP27A1 c.491G>A variant is predicted to result in the amino acid substitution p.Arg164Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.060% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-219676989-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Uncertain:1
The p.R164Q variant (also known as c.491G>A), located in coding exon 3 of the CYP27A1 gene, results from a G to A substitution at nucleotide position 491. The arginine at codon 164 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at